Analyzing RASSF1A Promoter Methylation and MicroRNA Profiles in the Plasma of Breast Cancer Patients from Pakistan
Current Trends in OMICS · 25.12.2025 · 5 (2) · 56-73
DOI: 10.32350/cto.52.04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Trends in OMICS, online erschienen am 25.12.2025. Verfasst von Jawaria Shaheen und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
The current study assessed the promoter DNA methylation status of a tumor suppressor gene, namely Ras association domain family 1 isoform A (RASSF1A), and the expression levels of selected cancer-associated microRNAs (miR-10b and miR-34a) in plasma samples of breast cancer patients, with the aim of evaluating the diagnostic relevance of circulating nucleic acids. Circulating cell free DNA (cfDNA) was isolated from the plasma samples of 40 breast cancer patients, followed by bisulfite modification and methylation-specific PCR to determine RASSF1A promoter hypermethylation. Further, miR-specific real-time qRT-PCR approach was used to analyse the levels of microRNA employing DNA primers, instead of stem-loop/locked nucleic acid (LNA) primers. RASSF1A promoter hypermethylation was detected in 40% of patients. Circulating miR-10b levels showed a statistically significant difference between patients and healthy controls (p < 0.001). Receiver operating characteristic (ROC) curve analysis demonstrated a high discriminative performance of miR-10b, with an area under the curve (AUC) of 0.97 (95% CI: 0.90–0.99; SE = 0.16). The results point to the potential value of circulating microRNA profiling, especially miR-10b, as an affordable and invasive supplement to the current breast cancer detection techniques. However, more validation research in a larger cohort is required to prove their therapeutic value.
Zitieren
APA
Shaheen, J., Firdous, S., Hassan, K. I., & Sadaf, S. (2025). Analyzing RASSF1A Promoter Methylation and MicroRNA Profiles in the Plasma of Breast Cancer Patients from Pakistan. Current Trends in OMICS, 5(2), 56-73. https://doi.org/10.32350/cto.52.04
Vancouver
Shaheen J, Firdous S, Hassan KI, Sadaf S. Analyzing RASSF1A Promoter Methylation and MicroRNA Profiles in the Plasma of Breast Cancer Patients from Pakistan. Current Trends in OMICS. 2025;5(2):56-73. doi:10.32350/cto.52.04
BibTeX
@article{Shaheen2025,
author = {Shaheen, Jawaria and Firdous, Safia and Hassan, Khulod Ibrahim and Sadaf, Saima},
title = {Analyzing RASSF1A Promoter Methylation and MicroRNA Profiles in the Plasma of Breast Cancer Patients from Pakistan},
journal = {Current Trends in OMICS},
year = {2025},
volume = {5},
number = {2},
pages = {56--73},
doi = {10.32350/cto.52.04}
}
EUVIMED